Search
Search Results
-
Adjuvant and Neoadjuvant Treatments for Resectable Hepatocellular Carcinoma
Purpose of ReviewThis review provides an update on the developments of adjuvant and neoadjuvant liver-directed and systemic therapy options for...
-
Network meta-analysis of adjuvant treatments for patients with hepatocellular carcinoma after curative resection
PurposeThe prevention of recurrence for patients with hepatocellular carcinoma after curative resection is still a great challenge in clinical...
-
The impact of erythropoiesis-stimulating agents administration concomitantly with adjuvant anti-HER2 treatments on the outcomes of patients with early breast cancer: a sub-analysis of the ALTTO study
PurposeTo assess whether erythropoiesis-stimulating agents (ESA) administration impacts the outcomes of patients with HER2-positive early breast...
-
Treatment of Recurrent Melanoma Following Adjuvant Therapy
In the era of effective therapies in melanoma, notably the widespread use of two types of adjuvant treatments: anti-PD-1 immunotherapies and...
-
-
Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma
Liver cancer, specifically hepatocellular carcinoma (HCC), is the sixth most common cancer and the third leading cause of cancer mortality worldwide....
-
Comparison of responses to neoadjuvant and adjuvant chemotherapies in muscle-invasive bladder cancer
BackgroundBladder cancer surgery is critical for treatment, and systemic treatment before or after cystectomy may be necessary. We aimed to...
-
Adjuvant chemotherapy versus adjuvant concurrent chemoradiotherapy after radical surgery for early-stage cervical cancer: a randomized, non-inferiority, multicenter trial
We conducted a prospective study to assess the non-inferiority of adjuvant chemotherapy alone versus adjuvant concurrent chemoradiotherapy (CCRT) as...
-
Small bowel adenocarcinomas with favorable prognoses by radical resection and adjuvant chemotherapy: a case series of five cases
BackgroundSmall bowel cancer is very rare, accounting for less than 5% of all gastrointestinal cancers, and small bowel adenocarcinoma accounts for...
-
Preferences for Adjuvant Immunotherapy in Adults with Resected Stage III Melanoma—A Discrete Choice Experiment
ObjectivesThis study aimed to quantify adult preferences for adjuvant immunotherapy for resected melanoma and the influence of varying levels of key...
-
Adjuvant treatment for locally advanced gastric cancer: an Asian perspective
Standard adjuvant treatment for locally advanced gastric cancer (LAGC) is regionally different. Whereas perioperative chemotherapy is the standard in...
-
The Role of Neoadjuvant and Adjuvant Chemotherapy in Pancreatic Cancer
Pancreatic cancer is an aggressive malignancy. Recurrences are very high despite high-quality surgery necessitating adjuvant therapy. The evolution...
-
The role of imaging features and resection status in the survival outcome of sporadic optic pathway glioma children receiving different adjuvant treatments
Optic pathway glioma (OPG) is a rare brain tumor affecting children, with no standard treatment strategy. This study described the sporadic OPG...
-
The role of central neck dissection and adjuvant treatment in pT4aN0 laryngeal carcinoma treated with open partial horizontal laryngectomy
PurposeThe study aimed to identify parameters that could predict oncological and functional outcomes in patients with pT4aN0 laryngeal squamous cell...
-
Bladder carcinosarcoma treated by cystectomy and adjuvant chemotherapy with good outcomes: a case report
BackgroundPrimary carcinosarcoma of the bladder is a rare and highly aggressive tumor, representing less than 1% of all bladder neoplasms. There is...
-
Personalizing adjuvant therapy for patients with colorectal cancer
The current standard-of-care adjuvant treatment for patients with colorectal cancer (CRC) comprises a fluoropyrimidine (5-fluorouracil or...
-
Adjuvant Chemotherapy With or Without Radiotherapy for Resected Pancreatic Cancer After Multiagent Neoadjuvant Chemotherapy
BackgroundAdjuvant therapy is associated with improved pancreatic cancer survival after neoadjuvant chemotherapy and surgery. However, whether...
-
Oncological and functional impact of adjuvant treatments after open partial laryngeal surgery: a systematic review of the literature and a meta-analysis
BackgroundThe oncological and functional role of postoperative radiotherapy (PORT) after open partial laryngeal surgery (OPLS) remains debatable.
...
-
Development and psychometric evaluation of the adjuvant endocrine therapy beliefs scale for breast cancer survivors
PurposeAdjuvant endocrine therapy has a vital role in reducing breast cancer mortality. The beliefs in adjuvant endocrine therapy is a very important...
